The University of Chicago Header Logo

Connection

James Millis to Time Factors

Back to Details
This is a "connection" page, showing publications James Millis has written about Time Factors.
James Millis
Connection Strength
0.336
Time Factors
  1. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
    View in: PubMed
    Score: 0.064
  2. A novel tunneling method for long-term peritoneal dialysis. Surg Endosc. 2005 Sep; 19(9):1291; author reply 1292.
    View in: PubMed
    Score: 0.036
  3. Bioartificial liver support: report of the longest continuous treatment with human hepatocytes. Transplant Proc. 2001 Feb-Mar; 33(1-2):1935.
    View in: PubMed
    Score: 0.026
  4. Safety of continuous human liver support. Transplant Proc. 2001 Feb-Mar; 33(1-2):1954.
    View in: PubMed
    Score: 0.026
  5. Biliary complications in living donor liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):419-20.
    View in: PubMed
    Score: 0.020
  6. Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):484.
    View in: PubMed
    Score: 0.020
  7. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
    View in: PubMed
    Score: 0.019
  8. Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
    View in: PubMed
    Score: 0.017
  9. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation. Transplantation. 1989 Jan; 47(1):82-8.
    View in: PubMed
    Score: 0.011
  10. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization. Dig Liver Dis. 2009 Feb; 41(2):175-6.
    View in: PubMed
    Score: 0.011
  11. Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg. 2007 Aug; 246(2):301-10.
    View in: PubMed
    Score: 0.010
  12. Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation. 2004 Apr 27; 77(8):1269-75.
    View in: PubMed
    Score: 0.008
  13. Transplantation of liver grafts from living donors into adults--too much, too soon. N Engl J Med. 2001 May 24; 344(21):1633-7.
    View in: PubMed
    Score: 0.007
  14. An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8.
    View in: PubMed
    Score: 0.005
  15. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
    View in: PubMed
    Score: 0.005
  16. Retransplantation for failed hepatic allografts in children. Transplant Proc. 1997 Feb-Mar; 29(1-2):442-3.
    View in: PubMed
    Score: 0.005
  17. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
    View in: PubMed
    Score: 0.005
  18. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.005
  19. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9.
    View in: PubMed
    Score: 0.005
  20. Late complications in kidney-pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3118.
    View in: PubMed
    Score: 0.005
  21. Role of liver transplantation in patients with hepatitis B infection. Clin Transplant. 1995 Jun; 9(3 Pt 2):269-76.
    View in: PubMed
    Score: 0.004
  22. Living-donor liver transplantation at UCLA. Am J Surg. 1995 May; 169(5):529-32.
    View in: PubMed
    Score: 0.004
  23. Radical resection combined with liver transplantation for foregut tumors. Am Surg. 1993 Dec; 59(12):806-12.
    View in: PubMed
    Score: 0.004
  24. The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation. 1990 Aug; 50(2):189-93.
    View in: PubMed
    Score: 0.003
  25. The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation. 1990 Aug; 50(2):219-25.
    View in: PubMed
    Score: 0.003
  26. Anti-tumor necrosis factor antibody enhances allograft survival in rats. J Surg Res. 1990 Apr; 48(4):345-8.
    View in: PubMed
    Score: 0.003
  27. Comparison of UW solution and Euro-Collins solutions for cold preservation of human liver grafts. Transplantation. 1990 Feb; 49(2):284-90.
    View in: PubMed
    Score: 0.003
  28. Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg. 1989 Jan; 209(1):51-6.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.